KHIDI Regenerative Medicine R&D (seed)
Funds Korean and partner teams advancing cell and gene therapies and tissue engineering in frontier healthcare innovation.
KHIDI identifies regenerative medicine as one of three priority next-generation healthcare technology areas within its Health Industry R&D support mandate, alongside innovative new drugs and medical devices. The regenerative medicine programme funds R&D in cell therapy, gene therapy, and tissue engineering — the three primary modalities of the field — with the goal of advancing Korea's position in…
Funds Korean R&D in cell therapy, gene therapy, and tissue engineering as a priority next-generation healthcare technology area within KHIDI's annual health industry support mandate.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
Write proposalGrant Writing Tips: Mistakes That Kill Deeptech Applications
Grant writing tips for deeptech founders, focused on mistakes reviewers penalize: weak fit, vague innovation, poor evidence, bad budgets, and rushed submissions.
More from KHIDI
All grants from this funder →KDDF New Drug R&D — staged-pipeline (seed)
🇰🇷KHIDI · South Korea
Funds Korean pharmaceutical teams through staged support from lead compounds through clinical development.
KHIDI Health Industry R&D Promotion (seed)
🇰🇷KHIDI · South Korea
Funds South Korea innovation teams building health-device and drug pipelines from proof to commercialization.
KHIDI Medical Device Industry Promotion (seed)
🇰🇷KHIDI · South Korea
Funds Korean medical-device firms with integrated support for certification, regulation, and global commercialization.
KHIDI Smart Hospital Leading Model (seed)
🇰🇷KHIDI · South Korea
Funds Korean hospitals and healthcare teams building smart hospital models for scalable digital care.
Similar grants
Browse the directory →
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.
KIAT Regional Industry Strategic R&D Program
🇰🇷KIAT · South Korea
Funds Korean regional teams with coordinated support for collaborative innovation in economic zones and parks.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.
Innovative Antimicrobials Against Resistant Pathogens
🇪🇺European Commission · European Union
Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.
TIPS General Track
🇰🇷MSS · South Korea
Offers Korean start-ups public and private co-investment pathways for product development and commercialization milestones.